Physician

Gary J Ganiban, M.D.

According to 2025 Medicare claims, Gary Ganiban, M.D. (NPI: 1306837281) practices ophthalmology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is ATLANTIC RETINA CONSULTANTS (NPI: 1649928490; TIN: 874384675) and primary practice location at 32901-1995. Ganiban is affiliated with the Aledade 149 Regional MSSP (ACO ID: A5231), participating under the MSSP model.

Ganiban's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,668 traditional Medicare patients, billed 16,123 HCPCS/CPT codes, and received $1,694,413 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 716 prescription claims across 234 beneficiaries totaling $53,102 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). 2018 DME data shows 11 claims. Open Payments data shows 8 records totaling $213. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,655	10,787	$1,137,116
2016	1,708	13,414	$1,751,733
2017	1,775	14,597	$2,013,527
2018	1,830	14,159	$2,072,309
2019	1,936	15,449	$2,523,029
2020	1,846	14,590	$2,748,113
2021	1,823	15,122	$3,035,134
2022	1,712	13,061	$2,561,450
2023	1,717	11,400	$1,714,487
2024	1,668	16,123	$1,694,413

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	219	504	$55,784
2016	190	501	$58,230
2017	200	582	$58,230
2018	223	672	$71,962
2019	235	681	$75,166
2020	239	727	$83,153
2021	237	691	$88,016
2022	243	770	$84,226
2023	208	592	$58,549
2024	234	716	$53,102

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$396
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	284	331	$92
67028	Injection of drug into eye	325	976	$90
92014	Established patient complete exam of visual system	1,332	2,107	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	247	322	$64
92134	Imaging of retina	1,321	2,697	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Combigan	Brimonidine Tartrate/Timolol	29	1,129	$7,669
Travoprost	Travoprost	37	1,377	$4,320
Brimonidine Tartrate	Brimonidine Tartrate	104	5,540	$3,624
Fluorometholone	Fluorometholone	15	1,052	$2,752
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	26	1,383	$2,497

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$213	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gary J. Ganiban, M.D.?

Tedicare shows public-source Medicare data for Gary J. Ganiban, M.D. (NPI 1306837281), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gary J. Ganiban, M.D. have ACO affiliation data?

Gary J. Ganiban, M.D. is shown with ACO affiliation data for Aledade 149 Regional MSSP (MSSP, ACO ID A5231).

What billing organization is linked to Gary J. Ganiban, M.D.?

Gary J. Ganiban, M.D. is linked to ATLANTIC RETINA CONSULTANTS (billing NPI 1649928490) in the available physician profile data.

Does Gary J. Ganiban, M.D. have Open Payments data?

Gary J. Ganiban, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.